SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-12G/A - Registration of securities [Section 12(g)]: [Amend]
SEC Accession No. 0000950115-99-000268
Filing Date
1999-02-24
Accepted
1999-02-24 00:00:00
Documents
6

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM FOR REGISTRATION OF SECURITIES 10-12G/A 294669
2 1999 STOCK OPTION PLAN EX-4.3.1 27243
3 CONSULTING AGREEMENT WITH PANKAJ MODI EX-10.1.2 10957
4 LETTER FROM FORMER ACCOUNTANT EX-16.1.1 1186
5 LETTER FROM FORMER ACCOUNTANT EX-16.1.2 1273
6 FDS EX-27 2334
  Complete submission text file 0000950115-99-000268.txt   339610
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO M5J A1
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-12G/A | Act: 34 | File No.: 000-25169 | Film No.: 99549051
SIC: 2834 Pharmaceutical Preparations